Search Results
Search for other papers by Rui-yi Tang in
Google Scholar
PubMed
Search for other papers by Rong Chen in
Google Scholar
PubMed
Search for other papers by Miao Ma in
Google Scholar
PubMed
Search for other papers by Shou-qing Lin in
Google Scholar
PubMed
Search for other papers by Yi-wen Zhang in
Google Scholar
PubMed
Search for other papers by Ya-ping Wang in
Google Scholar
PubMed
as kg/m 2 . The Tanner score was used to assess baseline secondary sexual characteristics. Because our centre is a tertiary hospital, many patients were referred to our hospital after having received some hormone treatment. Information regarding
Search for other papers by Nandini Shankara Narayana in
Google Scholar
PubMed
Search for other papers by Lam P Ly in
Google Scholar
PubMed
Search for other papers by Veena Jayadev in
Google Scholar
PubMed
Search for other papers by Carolyn Fennell in
Google Scholar
PubMed
Search for other papers by Sasha Savkovic in
Google Scholar
PubMed
Search for other papers by Ann J Conway in
Google Scholar
PubMed
Search for other papers by David J Handelsman in
Google Scholar
PubMed
sexual characteristics in males with hypogonadotropic hypogonadism . Journal of Sexual Medicine 2011 8 3471 – 3478 .
Search for other papers by Rafaella Sales de Freitas in
Google Scholar
PubMed
Search for other papers by Thiago F A França in
Google Scholar
PubMed
Search for other papers by Sabine Pompeia in
Google Scholar
PubMed
involves neuroendocrine changes leading to maturation of the gonads, acceleration of growth in height, and development of secondary sexual characteristics. The kisspeptin peptides, produced by small groups of neurons in the hypothalamus, play a key role in
Search for other papers by M Jensterle in
Google Scholar
PubMed
Search for other papers by A Podbregar in
Google Scholar
PubMed
Search for other papers by K Goricar in
Google Scholar
PubMed
Search for other papers by N Gregoric in
Google Scholar
PubMed
Search for other papers by A Janez in
Google Scholar
PubMed
been poor responders to LSM, by means of reversal of FH and WR. The primary outcome measures were changes in testosterone, sexual function and gonadotropins. The secondary outcomes were measures of obesity and metabolic profile. Materials and
Search for other papers by Yanfei Chen in
Google Scholar
PubMed
Search for other papers by Mei Li in
Google Scholar
PubMed
Search for other papers by Binrong Liao in
Google Scholar
PubMed
Search for other papers by Jingzi Zhong in
Google Scholar
PubMed
Search for other papers by Dan Lan in
Google Scholar
PubMed
development of internal and external reproductive organs and secondary sexual characteristics before the age of 8 in girls and 9 in boys ( 1 ). In recent years, the age of puberty initiation has been declining all over the world, paralleled by the increasing
Search for other papers by Mei Li in
Google Scholar
PubMed
Search for other papers by Yanfei Chen in
Google Scholar
PubMed
Search for other papers by Binrong Liao in
Google Scholar
PubMed
Search for other papers by Jing Tang in
Google Scholar
PubMed
Search for other papers by Jingzi Zhong in
Google Scholar
PubMed
Search for other papers by Dan Lan in
Google Scholar
PubMed
luteinizing hormone (LH) and follicle stimulating hormone (FSH). Central precocious puberty (CPP) is a common pediatric endocrine disease due to premature reactivation of the HPG axis leading to the development of secondary sexual characteristics before the
UPMC Univ, Paris, France
Search for other papers by Anne Bachelot in
Google Scholar
PubMed
Search for other papers by Magaly Vialon in
Google Scholar
PubMed
Search for other papers by Amandine Baptiste in
Google Scholar
PubMed
Search for other papers by Isabelle Tejedor in
Google Scholar
PubMed
Search for other papers by Caroline Elie in
Google Scholar
PubMed
Université Paris Descartes, Paris, France
Search for other papers by Michel Polak in
Google Scholar
PubMed
UPMC Univ, Paris, France
Search for other papers by Philippe Touraine in
Google Scholar
PubMed
Search for other papers by the CRMERC study group in
Google Scholar
PubMed
). Once growth is no longer a concern, a shift in treatment goals from optimization of growth and puberty to prevention of long-term adverse outcomes and optimization of fertility and sexual function is needed ( 5 , 6 , 7 , 8 , 9 , 10 ). The
Search for other papers by Shota Dzemaili in
Google Scholar
PubMed
Search for other papers by Jitske Tiemensma in
Google Scholar
PubMed
Search for other papers by Richard Quinton in
Google Scholar
PubMed
Search for other papers by Nelly Pitteloud in
Google Scholar
PubMed
Faculty of Nursing Science, Laval University, Québec City, Canada
Search for other papers by Diane Morin in
Google Scholar
PubMed
Endocrinology, Diabetes & Metabolism Service of the Centre Hospitalier Universitaire Vaudois, Lausanne, Switzerland
Search for other papers by Andrew A Dwyer in
Google Scholar
PubMed
induce secondary sexual characteristics and menses ( 4 ). Combined gonadotropin therapy or physiologic treatment with pulsatile GnRH are equally effective for inducing fertility in the vast majority of cases ( 10 ). Compared to fertile counterparts
Search for other papers by María J Gómora in
Google Scholar
PubMed
Search for other papers by Flavia Morales-Vásquez in
Google Scholar
PubMed
Search for other papers by Enrique Pedernera in
Google Scholar
PubMed
Search for other papers by Delia Perez-Montiel in
Google Scholar
PubMed
Search for other papers by Horacio López-Basave in
Google Scholar
PubMed
Search for other papers by Antonio R Villa in
Google Scholar
PubMed
Search for other papers by Azucena Hernández-Martínez in
Google Scholar
PubMed
Search for other papers by Esteban Mena in
Google Scholar
PubMed
Search for other papers by Carmen Mendez in
Google Scholar
PubMed
that can increase the incidence as well as tumor aggressiveness ( 8 , 9 , 10 ). Sexual steroid hormones acting through their receptors regulate signaling pathways related to cell proliferation, epithelial–mesenchymal transition, apoptosis, cell
Search for other papers by Lachlan Angus in
Google Scholar
PubMed
Search for other papers by Shalem Leemaqz in
Google Scholar
PubMed
Search for other papers by Olivia Ooi in
Google Scholar
PubMed
Search for other papers by Pauline Cundill in
Google Scholar
PubMed
Search for other papers by Nicholas Silberstein in
Google Scholar
PubMed
Search for other papers by Peter Locke in
Google Scholar
PubMed
Search for other papers by Jeffrey D Zajac in
Google Scholar
PubMed
Search for other papers by Ada S Cheung in
Google Scholar
PubMed
. Over 3–24 months, this leads to feminine physical characteristics including softening of skin, a decrease in facial and body hair growth, changes in body fat and muscle distribution, as well as breast development ( 4 ). Oestradiol improves psychological